Lifecore Biomedical Inc.
LFCR | NASDAQ
$4.47
-$0.01 (-0.22%)
Sep 22, 2026, 11:48 AM ET · Market open
Market Data
Market Cap $168.04M
Enterprise Value $305.87M
Beta 1.09
Average Volume 180.11K
Shares Outstanding (Diluted) 37.57M
Shares Change YoY 1.48%
Institutional Ownership 67.01%
Exchange NASDAQ
ISIN US5147661046
Price Performance
Price Change 1M -1.5%
Price Change 3M -20.9%
Price Change 6M 6.9%
Price Change YTD -42.1%
Price Change 1Y -43.1%
Price Change 3Y -44.3%
Price Change 5Y -56.2%
1M CAGR (ann.) -10.6%
1Y CAGR (ann.) -43.5%
5Y CAGR (ann.) -15.6%
All-Time CAGR -3.7%
Valuation
PE Ratio -4.07
Forward PE N/A
PEG Ratio 0.33
Forward PEG 0.32
PS Ratio 1.37
Forward PS 1.30
PB Ratio 10.44
P/FCF Ratio -93.51
P/Adj. FCF Ratio -16.71
P/OCF Ratio 74.67
EV/Sales 2.49
EV/EBIT -22.72
EV/EBITDA -73.90
EV/FCF -170.21
Earnings Yield -24.6%
FCF Yield -1.1%
Adj. FCF Yield -6.0%
Financial Health
Net Debt $137.83M
Total Debt $155.07M
Cash & Short-Term Investments $17.24M
Total Assets $229.5M
Current Ratio 3.87
Quick Ratio 2.69
Debt / Equity Ratio 9.64
Debt / EBITDA -37.47
Debt / FCF -86.29
OCF / Debt 0.01
Interest Coverage -0.09
Altman Z-Score -0.35
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 29.7%
Operating Profit Margin -2.1%
EBITDA Margin -3.4%
Net Profit Margin -30.4%
FCF Margin -1.5%
Adj. FCF Margin -8.2%
SBC / Revenue 6.7%
SBC Impact (per share) -459.6%
Returns
Return on Assets -16.3%
Return on Equity -376.9%
Return on Invested Capital -1.3%
Return on Capital Employed -1.3%
Return on Tangible Assets -17.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 7.9%
Revenue CAGR 5Y -22.9%
Revenue CAGR 10Y -13.8%
EPS CAGR 3Y -92.6%
EPS CAGR 5Y 36.3%
EPS CAGR 10Y -22.0%
FCF CAGR 3Y 73.0%
FCF CAGR 5Y 49.8%
FCF CAGR 10Y -1.7%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 7
EPS Growth Next 3Y 17.6%
Revenue Growth Next 3Y 14.5%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$0.30
EPS Growth Est (next Q) 2.6%
Revenue Est (next Q) $25.57M
Revenue Growth Est (next Q) -17.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $6.50
Price Target Upside 45.1%
Cash Flow
Operating Cash Flow $2.08M
Free Cash Flow $-1.8M
Adj. Free Cash Flow $-10.06M
FCF Per Share -$0.05
OCF Per Share $0.06
OCF/S Ratio 1.7%
Income Statement
Revenue $122.64M
Gross Profit $36.4M
Operating Income $-2.61M
EBITDA $-4.14M
Net Income $-37.28M
EPS (Diluted) -$1.10
Revenue / Employee $321.04K
Profit / Employee $-97.6K
Employees 382
Add to Watchlist
Select watchlists to add or remove LFCR